Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

被引:110
作者
Shih, LM [1 ]
Sheu, JJC
Santillan, A
Nakayama, K
Yen, MJ
Bristow, RE
Vang, R
Parmigiani, G
Kurman, RJ
Trope, CG
Davidson, B
Wang, TL
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol Gynecol & Oncol, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Dept Biostat, Baltimore, MD 21231 USA
[3] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[4] Univ Oslo, Norwegian Radium Hosp, Dept Gynecol Oncol, N-0310 Oslo, Norway
关键词
digital karyotyping; gene amplification; oncogene;
D O I
10.1073/pnas.0504195102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A genomewide technology, digital karyotyping, was used to identify subchromosomal alterations in ovarian cancer. Amplification at 11q13.5 was found in three of seven ovarian carcinomas, and amplicon mapping delineated a 1.8-Mb core of amplification that contained 13 genes. FISH analysis demonstrated amplification of this region in 13.2% of high-grade ovarian carcinomas but not in any of low-grade carcinomas or benign ovarian tumors. Combined genetic and transcriptome analyses showed that Rsf-1 (HBXAPalpha) was the only gene that demonstrated consistent overexpression in all of the tumors harboring the 11q13.5 amplification. Patients with Rsf-1 amplification or overexpression had a significantly shorter overall survival than those without. Overexpression of Rsf-1 gene stimulated cell proliferation and transform nonneoplastic cells by conferring serum-independent and anchorage-independent growth. Furthermore, Rsf-1 gene knockdown inhibited cell growth in OVCAR3 cells, which harbor Rsf-1 amplification. Taken together, these findings indicate an important role of Rsf-1 amplification in ovarian cancer.
引用
收藏
页码:14004 / 14009
页数:6
相关论文
共 29 条
[1]  
Boon K, 2005, CANCER RES, V65, P703
[2]  
BORG A, 1990, CANCER RES, V50, P4332
[3]  
Buckhaults P, 2003, CANCER RES, V63, P4144
[4]   Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter (Publication with Expression of Concern) [J].
Cosma, MP ;
Tanaka, TU ;
Nasmyth, K .
CELL, 1999, 97 (03) :299-311
[5]  
Di CH, 2005, CANCER RES, V65, P919
[6]   A role for the yeast SWI/SNF complex in DNA replication [J].
Flanagan, JF ;
Peterson, CL .
NUCLEIC ACIDS RESEARCH, 1999, 27 (09) :2022-2028
[7]  
Foster KW, 1999, CELL GROWTH DIFFER, V10, P423
[8]   Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice [J].
Guidi, CJ ;
Sands, AT ;
Zambrowicz, BP ;
Turner, TK ;
Demers, DA ;
Webster, W ;
Smith, TW ;
Imbalzano, AN ;
Jones, SN .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (10) :3598-3603
[9]   Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization:: a technical review with interpretive guidelines [J].
Hicks, DG ;
Tubbs, RR .
HUMAN PATHOLOGY, 2005, 36 (03) :250-261
[10]  
HOGARTY MD, 2002, GENETIC BASIS HUMAN, P115